Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2002 3
2004 1
2005 2
2006 6
2007 2
2008 9
2009 7
2010 9
2011 6
2012 5
2013 3
2014 3
2015 6
2016 6
2017 10
2018 18
2019 7
2020 8
2021 5
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Management of medication overuse headache.
D'Amico D, Grazzi L, Tepper SJ. D'Amico D, et al. Handb Clin Neurol. 2024;199:277-299. doi: 10.1016/B978-0-12-823357-3.00026-4. Handb Clin Neurol. 2024. PMID: 38307652 Review.
Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis.
Pezzolo E, Ortoncelli M, Ferrucci SM, Guanti MB, Schena D, Napolitano M, Rossi M, Foti C, D'Amico D, Amoruso GF, Morrone P, Ribero S, Barei F, Biagi M, Pascucci E, Patruno C, Calzavara Pinton P, Romita P, Gargiulo L, Narcisi A, Naldi L. Pezzolo E, et al. Among authors: d amico d. J Clin Med. 2024 Jan 18;13(2):553. doi: 10.3390/jcm13020553. J Clin Med. 2024. PMID: 38256686 Free PMC article.
Societal and personal impact of migraine.
Leonardi M, Guastafierro E, Toppo C, D'Amico D. Leonardi M, et al. Among authors: d amico d. Handb Clin Neurol. 2023;198:23-29. doi: 10.1016/B978-0-12-823356-6.00015-9. Handb Clin Neurol. 2023. PMID: 38043966 Review.
Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study).
Grazzi L, D'Amico D, Guastafierro E, Demichelis G, Erbetta A, Fedeli D, Nigri A, Ciusani E, Barbara C, Raggi A. Grazzi L, et al. Among authors: d amico d. J Headache Pain. 2023 Jul 14;24(1):86. doi: 10.1186/s10194-023-01630-0. J Headache Pain. 2023. PMID: 37452281 Free PMC article. Clinical Trial.
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Gottardi F, Baccelli F, Leardini D, Di Battista A, Castellucci P, D'Amico D, Serravalle S, Bertuccio SN, Messelodi D, Prete A, Masetti R. Gottardi F, et al. Among authors: d amico d. Br J Haematol. 2023 Sep;202(5):e39-e42. doi: 10.1111/bjh.18936. Epub 2023 Jun 22. Br J Haematol. 2023. PMID: 37350036 No abstract available.
Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy.
Dastoli S, Passante M, Loconsole F, Mortato E, Balato A, Piccolo V, Guarneri C, Macca L, Provenzano E, Valenti G, D'Amico D, Micali G, Musumeci ML, Palazzo G, Foti C, Romita P, Fabbrocini G, Megna M, Sammarra I, Bennardo L, Patruno C. Dastoli S, et al. Among authors: d amico d. J Dermatolog Treat. 2023 Dec;34(1):2200868. doi: 10.1080/09546634.2023.2200868. J Dermatolog Treat. 2023. PMID: 37026590 Free article.
A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache.
Grazzi L, Raggi A, Guastafierro E, Passavanti M, Marcassoli A, Montisano DA, D'Amico D. Grazzi L, et al. Among authors: d amico d. Int J Environ Res Public Health. 2022 Oct 29;19(21):14116. doi: 10.3390/ijerph192114116. Int J Environ Res Public Health. 2022. PMID: 36360996 Free PMC article. Clinical Trial.
Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway.
D'Amico D, Biondi O, Januel C, Bezier C, Sapaly D, Clerc Z, El Khoury M, Sundaram VK, Houdebine L, Josse T, Della Gaspera B, Martinat C, Massaad C, Weill L, Charbonnier F. D'Amico D, et al. Neuropathol Appl Neurobiol. 2022 Aug;48(5):e12816. doi: 10.1111/nan.12816. Epub 2022 Mar 30. Neuropathol Appl Neurobiol. 2022. PMID: 35338505
118 results